Two case reports of Clostridium difficile bacteremia, one with the epidemic NAP-1 strain

Infection

Volumn 39, Issue 4, 2011, Pages 371-373

  Hemminger, J ^a   Balada Llasat, J M ^a   Raczkowski, M ^a   Buckosh, M ^a   Pancholi, P ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Bacteremia; BI NAP 1; Clostridium difficile

Indexed keywords

AMIKACIN; BACTERIAL TOXIN; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CANDIDA GLABRATA; CASE REPORT; CECUM DISEASE; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COLON OBSTRUCTION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DIVERTICULOSIS; DRUG EFFICACY; EPIDEMIC; ESCHERICHIA COLI; FECES ANALYSIS; HEART ATRIUM FIBRILLATION; INTESTINE PERFORATION; LAPAROTOMY; LEUKOCYTOSIS; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYSICAL EXAMINATION; PNEUMONIA; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RECURRENT CANCER; TREATMENT DURATION;

EID: 85027918142     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-011-0115-7     Document Type: Article

References (17)

1. Delmée M. Laboratory diagnosis of Clostridium difficile disease. Clin Microbiol Infect. 2001;7:411-6. (Pubitemid 34960331)
2. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol. 2009;7:526-36.
3. Mc Master-Baxter NL, Musher DM. Clostridium difficile: recent epidemiologic findings and advances in therapy. Pharmacotherapy. 2007;27:1029-39. (Pubitemid 46986690)
4. Naggie S, Frederick J, Pien BC, Miller BA, Provenzale DT, Goldberg KC, Woods CW. Community-associated Clostridium difficile infection: experience of a veteran affairs medical center in southeastern USA. Infection. 2010;38:297-300.
5. Libby DB, Bearman G. Bacteremia due to Clostridium difficile\- review of the literature. Int J Infect Dis. 2009;13:e305-9.
6. Limbago BM, Long CM, Thompson AD, Killgore GE, Hannett GE, Havill NL, Mickelson S, Lathrop S, Jones TF, Park MM, Harriman KH, Gould LH, Mc Donald LC, Angulo FJ. Clostridium difficile strains from community-associated infections. J Clin Microbiol. 2009;47:3004-7.
7. Denève C, Janoir C, Poilane I, Fantinato C, Collignon A. New trends in Clostridium difficile virulence and pathogenesis. Int J Antimicrob Agents. 2009;33:S24-8.
8. Kuijper EJ, Barbut F, Brazier JS, Kleinkauf N, Eckmanns T, Lambert ML, Drudy D, Fitzpatrick F, Wiuff C, Brown DJ, Coia JE, Pituch H, Reichert P, Even J, Mossong J, Widmer AF, Olsen KE, Allerberger F, Notermans DW, Delmée M, Coignard B, Wilcox M, Patel B, Frei R, Nagy E, Bouza E, Marin M, Akerlund T, Virolainen-Julkunen A, Lyytikäinen O, Kotila S, Ingebretsen A, Smyth B, Rooney P, Poxton IR, Monnet DL. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill. 2008;13:1-7.
9. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Mi-chaud S, Bourgault A-M, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, René P, Monczak Y, Dascal A. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353:2442-9. (Pubitemid 41770165)
10. Mc Donald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, Johnson S, Gerding DN An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433-41. (Pubitemid 41770164)
11. Dupuy B, Govind R, Antunes A, Matamouros S. Clostridium difficile toxin synthesis is negatively regulated by Tcd C. J Med Microbiol. 2008;57:685-9. (Pubitemid 351842058)
12. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, Frost E, Mc Donald LC. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe dis-ease in North America and Europe. Lancet. 2005;366:1079-84 (Pubitemid 41338761)
13. García-Lechuz JM, Hernangómez S, San Juan R, Peláez T, Alcalá L, Bouza E. Extra-intestinal infections caused by Clostridium difficile. Clin Microbiol Infect. 2001;7:453-7. (Pubitemid 34960340)
14. Zheng L, Citron DM, Genheimer CW, Sigmon SF, Carman RJ, Lyerly DM, Goldstein EJC. Molecular characterization and antimicrobial susceptibilities of extra-intestinal Clostridium dif-ficile isolates. Anaerobe. 2007;13:114-20. (Pubitemid 47268793)
15. Elliott B, Reed R, Chang BJ, Riley TV. Bacteremia with a large clostridial toxin-negative, binary toxin-positive strain of Clos-tridium difficile. Anaerobe. 2009;15:249-51.
16. Brazier JS, Raybould R, Patel B, Duckworth G, Pearson A, Charlett A, Duerden BI; HPA Regional Microbiology Network. Distribution and antimicrobial susceptibility patterns of Clos-tridium difficile PCR ribotypes in English hospitals, 2007-08. Euro Surveill. 2008;13:1-4.
17. Spigaglia P, Barbanti F, Mastrantonio P, Brazier JS, Barbut F, Delmée M, Kuijper E, Poxton IR; European Study Group on Clostridium difficile (ESGCD). Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. dif-ficile infections in Europe. J Med Microbiol. 2008;57:784-9. (Pubitemid 351842073)